It has been illustrated that TIGIT inhibition on NK cells suppresses metastatic breast cancer cells, MDA MB-453 through provoking the cytotoxic activities and IFN-γ synthesis of NK cells [116]. The gene discussed is IFNG; the disease is breast cancer.